Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.

Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.

Item
http://www.wikidata.org/entity/Q38746593
Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines.Targeting bromodomain and extraterminal proteins in breast cancer.Somatostatin receptor subtype 1 as a potential diagnostic marker and therapeutic target in prostate cancer.Overcoming resistance to DNA targeted agents by epigenetic activation of Schlafen 11 (SLFN11) expression with class I histone deacetylase inhibitors.Exploiting histone deacetylases for cancer therapy: from hematological malignancies to solid tumors.L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway.STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancerNovel hybrid molecule overcomes the limited response of solid tumours to HDAC inhibitors via suppressing JAK1-STAT3-BCL2 signalling
P2860

Feedback Activation of Leukemia Inhibitory Factor Receptor Limits Response to Histone Deacetylase Inhibitors in Breast Cancer.

Item
http://www.wikidata.org/entity/Q38746593
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Feedback Activation of Leukemi ...... e Inhibitors in Breast Cancer.
@en
type
label
Feedback Activation of Leukemi ...... e Inhibitors in Breast Cancer.
@en
prefLabel
Feedback Activation of Leukemi ...... e Inhibitors in Breast Cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Feedback Activation of Leukemi ...... se Inhibitors in Breast Cancer
@en
P2093
P304
P31
P356
10.1016/J.CCELL.2016.08.001
P433
P478
P50
P577
P698